Clinical Trial Update: Prevention of Bleeding in Patients With Moderate and Severe Hemophilia A Playing Sports: A Comparison Between Factor VIII and Emicizumab Prophylaxis

View source ↗

Summary

A clinical trial is evaluating bleeding prevention in moderate-to-severe Hemophilia A patients who play sports, comparing Factor VIII prophylaxis with Emicizuma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• Emicizumab (emicizumab)
• Factor VIII (Factor VIII)

Snippet

Sponsor: Wayne State University | Conditions: Hemophilia A | Status: RECRUITING